Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-017-0310-x
Full Text
Open PDFAbstract
Available in full text
Date
January 19, 2018
Authors
Publisher
BMJ